Abbott to pay $384M over tainted infant formula
Abbott agreed to settle federal and state allegations that it manufactured and sold potentially contaminated infant formula after unsanitary conditions were found at its Michigan and Arizona plants.
Abbott Laboratories, the company behind the massive 2022 formula shortage that sparked widespread panic, has agreed to pay more than $384 million to settle allegations that it manufactured and sold potentially contaminated infant formula to government programs, according to the Department of Justice.